¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ȯ"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
monorchism
Ȭ°íȯÁõ, ´ÜÀϰíȯÁõ
monosubstituted
´ÜÀÏġȯ-
mood-congruent hallucination
±âºÐÀÏġȯ°¢
mood-incongruent hallucination
±âºÐºÒÀÏġȯ°¢
morbid
1. º´Àû- 2. ÀÌȯ-
morbidity
1. ÀÌȯ 2. ÀÌȯÀ²
morbidity rate
ÀÌȯÀ²
morbidity statistics
ÀÌȯÅë°è
morbidity survey
ÀÌȯÀ²Á¶»ç
morbus
º´, Áúº´, Áúȯ
multifactorial genetic disorder
´ÙÀÎÀÚÀ¯ÀüÁúȯ
malignant transformation
¾Ç¼ºÀüȯ
mumps orchitis
º¼°Å¸®°íȯ¿°
myelodysplastic disorder
°ñ¼öÇü¼ºÀÌ»óÁúȯ, °ñ¼öÇü¼ºÀå¾Ö
myeloproliferative disorder
°ñ¼öÁõ½ÄÁúȯ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
gubernaculum testis
°íȯ±æÀâÀÌ
gas exchange ratio
°¡½º±³È¯ºñÀ²
gene replacement
À¯ÀüÀÚ±³È¯
index group
ÃʹßȯÀÚ±º
papular annular granuloma
±¸Áø°í¸®À°¾ÆÁ¾, ±¸ÁøÈ¯»óÀ°¾ÆÁ¾
hallucination of memory
±â¾ïȯ°¢
hebephreniac
»çÃá±âÄ¡¸ÅȯÀÚ
hematodyscrasia
(¢¡blood dyscrasia) Ç÷¾×Áúȯ
hemophiliac
Ç÷¿ìº´È¯ÀÚ
hepatism
°£ÁúȯÁõ
hepatopath
°£Àå¾ÖȯÀÚ
homocyclic
µ¿¼Òȯ½Ä-
hyperkinemia
¼øÈ¯Ç÷·ù·®°ú´Ù
hyperkinemic
¼øÈ¯Ç÷·ù·®°ú´Ù-
hypoventilation
È£ÈíÀúÇÏ, ȯ±âÀúÇÏ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
hydrogen ion exchange
¼ö¼ÒÀ̿±³È¯.
hyperbaric atmosphere
°í¾Ðȯ°æ.
hypercapneic hypoventilation
°íź»êÇ÷Áõ¼º Àúȯ±â(¡î¸üµÑ¨).
hypergonadotropic eunuchoidism
°í³ªµµÆ®·ÎÇɰúÀ×¼º À¯È¯°üÁõ(¡Î¦í¥àõ×¾ü²Î¯ ñø).
hyperkinemia
¼øÈ¯Ç÷·ù·®°ú´Ù.
hyperkinemic
¼øÈ¯Ç÷·ù·®°ú´ÙÀÇ.
hyperkinetic circulatory state
¿îµ¿°úÀ×¼º ¼øÈ¯»óÅÂ(¡âàü»ßÒ÷¾).
hyperkinetic circulatory state
°ú¿îµ¿¼º ¼øÈ¯»óÅÂ(¡âàü»ßÒ÷¾).
hyperope
¿ø½Ã(ȯ)ÀÚ(êÀãÊäÑü´íº).
hypersensitivity disorders
°ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
hypertensive diseases
°íÇ÷¾Ð¼º Áúȯ.
hypertensive heart disease
°íÇ÷¾Ð¼º ½ÉÁúȯ(¡ãýòðü´)
hypertensive heart disease =HHD
°íÇ÷¾Ð¼º ½ÉÀåÁúȯ.
hypertensive heart disease =HHD
°íÇ÷¾Ð¼º ½ÉÁúȯ.
hypertensive vascular disease
°íÇ÷¾Ð¼º Ç÷°üÁúȯ(¡úìηòðü´).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
cell transformation
¼¼Æ÷ÇüÁúÀüȯ, ¼¼Æ÷º¯Çü
cell, transformed
ÇüÁúÀüȯ¼¼Æ÷
cenesthetic hallucination
ü°¨È¯°¢
cephalopathy
µÎºÎÁúȯ
cerebral circulation
³ú¼øÈ¯(Òàâàü»).
cerebral vascular disease
³úÇ÷°üÁúȯ.
cerebrovascular disease
³úÇ÷°üÁúȯ(¡òðü´).
cerebrovascular disease
³úÇ÷°üÁúȯ(¡òðü´).
cerebrovascular disease
³úÇ÷°üÁúȯ(Òàúìηòðü´)
ceroid storage disease
¼¼·ÎÀ̵åÃàÀûÁúȯ.
cervical disease
Àڱðæ(ºÎ)Áúȯ(íÏàÌòÝ»òðü´).
chart
ȯÀÚ±â·ÏÁö, µµÇ¥, ÇØµµ.
chemical environment
ÈÇÐȯ°æ
chloride-bicarbonate exchange
¿°¼Ò Áßź»ê À̿±³È¯
chop amputation
Æò¸é ȯ»ó Àý´Ü(øÁØüü»ßÒôîÓ¨).
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
20
ÄÚµå
¿µ¹®
ÇѱÛ
E29.0
Testicular hyperfunction
°íȯ °úµµ±â´É
E29.1
Testicular hypofunction
°íȯ ±â´ÉÀúÇÏ
E29.8
Other testicular dysfunction
±âŸ °íȯ ±â´ÉÀÌ»ó
E29.9
Testicular dysfunction, unspecified
»ó¼¼ºÒ¸íÀÇ °íȯ ±â´ÉÀÌ»ó
E32
Diseases of thymus
°¡½¿»ùÀÇ Áúȯ
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
¼³¸í
pseudo-pili annulati
°¡¼º ȯ»ó ¸ð¹ß
PSTN
°øÁßÀüȸÁ, °øÁßÀüȱ³È¯¸Á
psychedelic agent
ȯ°¢Á¦
psychedelics
ȯ°¢Á¦
pulmonary arterial hypertension
Æó ¼øÈ¯ ½Â¾Ð
pulmonary hypertension
Æó ¼øÈ¯ ½Â¾Ð, Æó °íÇ÷¾ÐÁõ
redox
»êÈ È¯¿ø
»óÈ£ »êÈ, ȯ¿øÇÏ´Â ÈÇÐ °úÁ¤.
reducase
ȯ¿ø È¿¼Ò
»ý¸®ÇÐÀûÀ¸·Î ´Ù¸¸ ´ë»ç¹°ÀÇ È¯¿ø¿¡¸¸ ÀÌ¿ëµÇ´Â ¹ÝÀÀÀ» Ã˸ÅÇÏ´Â »êÈ È¯¿ø È¿¼Ò Á¾·ùÀÇ ÇÑ È¿¼Ò.
reducible
ȯ¿øÇÒ ¼ö ÀÖ´Â
reducing agent
ȯ¿øÁ¦, ȯ¿ø ¹°Áú
reducing flux
ȯ¿ø À¶Á¦
retentive circumferential clasp arm
ȯÇü À¯Áö ¿Ï±¸
reverse mutation
ȯ¿ø µ¹¿¬ º¯ÀÌ
rights of patients
ȯÀÚ ±Ç¸®, ȯÀÚÀÇ ±Ç¸®
ring enhancement
ȯ»ó Á¶¿µ Áõ°
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
claustrophobic
¹Ð½Ç°øÆ÷ÁõÀÇ;¹Ð½Ç °øÆ÷ÁõȯÀÚ
clear
¹àÀº;¸¼°Ô °µ;¼±¸íÇÑ;(´Þ.º° µîÀÌ)¹àÀº;(ºÒ.ºû µîÀÌ)Ÿ¿À¸£´Â;ºû³ª´Â;¸¼Àº;Åõ¸íÇÑ;(¾È»ö.ÇǺλö µîÀÌ)¸¼Àº;ȯÇÑ;(¼Ò¸®°¡)¸¼Àº;¶Ñ·ÇÇÑ;(À½ÀÌ)¸¼Àº;(»ç½Ç.ÀǹÌ.Áø¼ú µîÀÌ)¸í¹éÇÑ;¸íÈ®ÇÑ;ºÐ¸íÇÑ;(µÎ¿Ü.»ç°í µîÀÌ)¸í¼®ÇÑ;¸í·áÇÑ;¶Ñ·ÇÇÑ;ÅõöÇÑ;(À±°û.¿µ»ó µîÀÌ)¶Ñ·ÇÇÑ;¿¸°;(¹æÇØ
clear
(¼¼°üÀ»)Åë°úÇÏ´Ù;°ü¼¼¸¦ ÁöºÒÇÏ´Ù;ÃâÇ× ÀýÂ÷¸¦ ¸¶Ä¡´Ù;(ºú µîÀ»)û»êÇÏ´Ù;(¾îÀ½À»)±³È¯ û»êÇÏ´Ù;(¼öÇ¥¸¦)Çö±ÝÀ¸·Î ¹Ù²Ù´Ù;(¼±¹Ú.»ç¶÷ µî¿¡)Ãâ±¹(ÀÔ±¹)Çã°¡¸¦ ÁÖ´Ù;(ºñÇà±â¿¡ ÀÌÂø·úµîÀÇ)Çã°¡¸¦ ÁÖ´Ù;(°èȹ.Á¦¾È µîÀ» À§¿øÈ¸ µî¿¡¼)½ÂÀÎ(ÀÎÁ¤)¹Þ´Ù;(...À»)Çã°¡(Àΰ¡)ÇÏ´Ù;(
clear light
=LSD(ȯ°¢Á¦)
clearance
Á¤¸®;Á¦°Å;Á¤µ·;¹èÁ¦;»ï¸²¹úä(°³°£À» À§ÇÑ);Åë°ü ÀýÂ÷;¼¼°ü Åë°ú;ÃâÇ×(Àΰ¡);(Ç×°ø±âÀÇ)Âø·ú(ÀÌ·ú)Çã°¡;Ŭ¸®¾î·±½º;(±âȹ µî¿¡ ´ëÇÑ »ó»ç µîÀÇ)Çã°¡;¿ÀÄÉÀÌ;¾îÀ½ ±³È¯(¾×);°áÁ¦;°Å·¡ °ü°èÀÇ ¿Ï·á;Àç°í Á¤¸®;Àç°í Á¤¸® ÆÇ¸Å;¿©À¯;Æ´;À¯±Ø
clearing
(»ï¸² ¼ÓÀÇ)°³Ã´Áö;û»ê;¾îÀ½ ±³È¯;¾îÀ½ ±³È¯¾×;û¼Ò;Àå¾Ö¹° Á¦°Å;¼ÒÇØ
clearing bank
¾îÀ½ ±³È¯ Á¶ÇÕ ÀºÇà
clearinghouse
¾îÀ½ ±³È¯¼Ò;Á¤º¸ ¼¾ÅÍ;¹°ÀÚ Áý¹è ¼¾ÅÍ
clientele
¼Ò¼ÛÀÇ·ÚÀÎ;(È£ÅÚ.±ØÀå.»óÁ¡ µîÀÇ)°í°´;´Ü°ñ ¼Õ´Ô;ȯÀÚ;ÇǺ¸È£ÀÚ;ºÎÇϵé
climacteric
Àüȯ±â¿¡ ÀÖ´Â;À§±âÀÇ(critical);¾×³âÀÇ;°»³â±âÀÇ;¿ù°æÆóÁö±âÀÇ;¾×³â(7³â¸¶´Ù,¶Ç´Â ±× ±â¼ö¹èÀÇ ÇØ);À§Çè±â;À§±â;Àüȯ±â;°»³â±â;Æó°æ±â
coin changer
µ¿Àü ±³È¯±â
cojones
°íȯ;ºÒ¾Ë;¿ë±â
cold turkey
¼ÖÁ÷ÇÑ À̾߱â;³ë°ñÀûÀÎ À̾߱â;(¸¶¾à ȯÀÚ¿¡°Ô)°©Àڱ⠸¶¾à »ç¿ëÀ» ÁßÁö½ÃÅ´;³Ã´ãÇÑ »ç¶÷
comic relief
(ºñ±ØÀûÀÎ Àå¸é¿¡ »ðÀÔÇÏ´Â)Èñ±ØÀûÀÎ ±âºÐ Àüȯ
commercial paper
»ó¾÷¾îÀ½(ȯ¾îÀ½.¼öÇ¥.¾à¼Ó ¾îÀ½ µîÀÇ ÃÑĪ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½